⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1636434 | 1.00 | — | — | |
| SCHEMBL2548243 | 1.00 | — | — | |
| SCHEMBL22328489 | 1.00 | — | — | |
| SCHEMBL12128106 | 1.00 | — | — | |
| SCHEMBL1842046 | 1.00 | — | — | |
| SCHEMBL438542 | 1.00 | — | — | |
| SCHEMBL11721774 | 0.85 | — | — | |
| SCHEMBL10917219 | 0.83 | CHRNB2 (0.34) | — | |
| SCHEMBL11627899 | 0.81 | — | — | |
| SCHEMBL14380103 | 0.79 | EPHX1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5665765-A | TREATMENT OF PARKINSON'S DISEASE, MEMORY DISORDERS, DISORDERS ASSOCIATED WITH DRUG ABUSE, DEPRESSION, AND PSYCHOTIC STATES | ADIR ET COMPAGNIE (FR) | 1997-09-09 | — | — | US | disclosed |